The study, published in Cardiovascular Diabetology, examined 4,048 participants from the China Health and Retirement Longitudinal Study (CHARLS) who had a 2015 landmark date.
The research addressed a specific gap in understanding how cumulative metabolic-inflammatory burden and self-reported functional limitations contribute to cardiovascular disease prognosis in individuals with stages 0–3 of cardiovascular–kidney–metabolic syndrome. The investigators sought to determine whether these two distinct types of cumulative measures provide complementary information for risk assessment.
The study defined the cumulative C-reactive protein–triglyceride glucose index, or CTI, using measurements from 2011 and 2015. In contrast, the functional limitation burden was calculated using a seven-task assessment from 2011, 2013, and 2015. Incident cardiovascular disease was defined as physician-diagnosed heart disease or stroke, identified during follow-up visits in 2018 and 2020.
During the follow-up period, 778 participants developed cardiovascular disease. The statistical analysis used mutually adjusted Cox proportional hazards models and alternative event-time models to account for the complex nature of the data. The primary results showed that for every one standard deviation increase in the cumulative CTI, the hazard ratio for developing cardiovascular disease was 1.11, with a 95% confidence interval of 1.03 to 1.20. For the cumulative functional limitation burden, the hazard ratio was significantly higher at 1.30, with a 95% confidence interval of 1.22 to 1.39.
Further analysis revealed that the association between functional limitation burden and cardiovascular disease remained consistent across different statistical models. In complementary log-log and interval-censored models, the hazard ratios for functional limitation burden were 1.30 and 1.31, respectively. In contrast, the estimates for the cumulative CTI were attenuated in these alternative models, dropping to 1.07 with a p-value of 0.073 in one model and 1.07 with a p-value of 0.063 in the other.
The study also evaluated the predictive performance of these measures using internal validation techniques, including 10-fold cross-validation and 500 full-pipeline bootstrap resamples. Adding the functional limitation burden to a model that already included conventional risk factors and the CTI increased the C-index by 0.0208, with a 95% confidence interval of 0.0102 to 0.0335. The integrated time-dependent area under the curve also improved by 0.0230. Additionally, the integrated Brier score difference was -0.0014, indicating a small but statistically significant absolute reduction in prediction error.
However, the study highlights important limitations in the interpretation of these findings. While the functional limitation burden showed consistent adjusted associations and internal prediction gains, the absolute reduction in prediction error was small. The researchers noted that AUC-specific superiority and clinical net benefit were not established. Furthermore, the study did not demonstrate that these measures lead to improved patient outcomes. The CTI was found to be event-time sensitive, and the superiority of functional limitation AUC over mean or recent scores was not proven.
The authors conclude that external validation and calibration are necessary before these cumulative measures can be used in clinical settings.
Subject of Research: Associations of cumulative metabolic and functional measures with incident cardiovascular disease in cardiovascular–kidney–metabolic syndrome
Article Title: Associations of cumulative C-reactive protein–triglyceride glucose index and cumulative functional limitation burden with incident cardiovascular disease among individuals with stages 0–3 cardiovascular–kidney–metabolic syndrome: a nationwide prospective cohort study
Article References: Yu, Z., Zhang, Z., Zha, J., Xiong, Y., Chen, H., Deng, L., & Zhang, X. (2026). Associations of cumulative C-reactive protein–triglyceride glucose index and cumulative functional limitation burden with incident cardiovascular disease among individuals with stages 0–3 cardiovascular–kidney–metabolic syndrome: a nationwide prospective cohort study. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-026-03438-z
Image Credits: AI Generated
DOI: 10.1186/s12933-026-03438-z
Keywords: cardiovascular-kidney-metabolic syndrome, functional limitation burden, C-reactive protein–triglyceride glucose index, incident cardiovascular disease, prospective cohort study, China Health and Retirement Longitudinal Study, cardiovascular risk prediction, metabolic-inflammatory burden, Cox proportional hazards models, internal validation, integrated Brier score, event-time models, physician-diagnosed heart disease, stroke incidence, longitudinal data analysis, risk stratification, clinical net benefit, external validation, trapezoidal integration, cardiovascular Diabetology
News Source: Frances Kline. (November 12, 2026). Functional Limitations Predict Heart Disease Risk in CKM Syndrome. Scienmag.



